Neutrophil Gelatinase-Associated Lipocalin: A New Marker of Renal Function in C-Related End Stage Liver Disease

Table 1

Comparison of the baseline data in both groups.

	Group I	Group II
	GFR < 60 mL/m	GFR ≥ 60 mL/m
	M ± SD	M ± SD
Age (years)	51.17 ± 7.61	47.80 ± 8.90		0.06
Gender
Female ()	8	9	0.26
Male ()	27	56
MAP (mmHg)	80.86 ± 6.48	80.46 ± 6.87	0.780
CTP score	10.14 ± 1.48	10.08 ± 1.46	0.831
MELD	23.71 ± 3.99	20.09 ± 5.78	0.002
MELD Na	28.40 ± 3.22	25.69 ± 5.62	0.025
Total bilirubin (mg/dL)	5.45 ± 5.64	4.16 ± 3.20	0.450
Albumin (g/dL)	2.48 ± 0.50	2.44 ± 0.45	0.733
AST (u/L)	74.11 ± 43.30	75.67 ± 43.51	0.865
ALT (u/L)	49.83 ± 26.90	52.62 ± 30.80	0.653
Hemoglobin (g/dL)	9.60 ± 1.03	10.54 ± 1.64	0.003
WBCs ×10^3/L	5.60 ± 3.19	5.74 ± 3.22	0.831
Platelets ×10^3/L	103.57 ± 26.29	93.12 ± 51.53	0.265
INR	1.77 ± 0.30	1.69 ± 0.27	0.195

Mann-Whitney test, GFR: glomerular filtration rate, MAP: mean arterial pressure, CTP: Child Pugh score, and MELD: model of end stage liver disease; .